Sanofi Consumer Healthcare Declared Massive ₹55 Final Dividend; Check Record Date

Sanofi Consumer Healthcare India, a subsidiary of global pharmaceutical giant Sanofi, has announced a final dividend of ₹55 per share for the financial year ending December 31, 2024. The company’s shares closed 1.42% higher at ₹4,815 on Thursday, March 6, 2025, following the announcement, bringing its market capitalization to ₹11,090 crore.

Sanofi Consumer Healthcare Dividend Details

According to the company’s regulatory filing:

 

  • Final Dividend Amount: ₹55 per share
  • Face Value of Share: ₹10
  • Record Date: April 28, 2025
  • Book Closure Dates: April 29, 2025 – May 5, 2025
  • Dividend Payment Subject to: Shareholder approval at the 2nd Annual General Meeting

Sanofi Consumer Healthcare sells popular consumer healthcare products under brands like Allegra, DePURA, Avil, and Combiflam in India.

Sanofi Consumer Healthcare Financial Performance

The company reported a decline in its financials for the December 2024 quarter:

  • Net Profit: ₹44.3 crore, down 34.8% YoY (from ₹67.9 crore)
  • Revenue: ₹170.7 crore, down 24% YoY (from ₹224.6 crore)
  • EBITDA: ₹61.1 crore, down 30.6% YoY (from ₹89.5 crore)
  • EBITDA Margin: 36.4%, down from 39.9% YoY

Sanofi Consumer Healthcare Share Price Outlook

Despite a prolonged downtrend, Sanofi’s stock has shown early signs of recovery, according to Mandar Bhojane, Equity Research Analyst at Choice Broking.

  • Current Price: ₹5,415
  • Rebounded 11% from ₹4,900 support level
  • Key Resistance Levels: ₹5,500 (breakout could push towards ₹5,800–₹5,900)
  • Key Support Levels: ₹5,300 (holding this level could signal further upside)
  • Stop-Loss Recommendation: ₹5,100

Bhojane notes that if Sanofi closes above its 20-day EMA and breaches the 50-day & 200-day EMAs, it could further strengthen its bullish trend. However, a drop below ₹5,300 could signal renewed selling pressure.

Is It Time to Buy Sanofi Stock?

With a ₹55 dividend payout and potential trend reversal, investors might find this a buying opportunity. However, monitoring resistance levels and volume trends is crucial before making investment decisions.

Also Check: 

Sanofi Consumer Healthcare

Bharat Electronics Ltd. (BEL) Declares Interim Dividend 2025!

 

Airtel eyes market leadership with Tata Play merger

(Disclaimer: The information in this article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult a financial expert before making investment decisions. Stock market investments are subject to risks, and past performance does not guarantee future returns.)

Leave a Comment